Vapotherm, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year 2019
January 10, 2020 at 06:00 am
Share
Vapotherm, Inc. provided earnings guidance for the fourth quarter and full year 2019. For the quarter, the company's preliminary revenue for the fourth quarter of 2019 is expected to be approximately $12.9 million, an increase of approximately 10% when compared with $11.7 million for the fourth quarter of 2018.
For the year, the company's preliminary revenue to be approximately $48.0 million, an increase of approximately 13% when compared with $42.4 million for the full year 2018.
Vapotherm, Inc. is a developer and manufacturer of advanced respiratory technology. It develops non-invasive technologies for respiratory support of patients with chronic or acute breathing disorders. It is focused on the care of patients suffering from respiratory distress, whether associated with lung diseases, such as chronic obstructive pulmonary disease, congestive heart failure, pneumonia, asthma, and COVID-19 or other systemic conditions. Its device solutions are focused on High Velocity Nasal Insufflation, which delivers non-invasive ventilatory support to patients by providing heated, humidified, oxygenated air at high velocities through a small-bore nasal interface, and on closed loop control systems, such as its Oxygen Assist Module, designed to automatically maintain a patients pulse oxygen saturation levels within a specified range for a defined period of time. Its digital solutions are focused on remote patient monitoring, using algorithms to predict respiratory episodes.
VAPOTHERM, INC. 
